This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Determine whether a 6-month or 12-month fund is right for you by assessing income stability, essential expenses, and personal risk appetite.
15,911 articlesA major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
A fast-moving convergence of quantum computing and robotics is reshaping portfolios. Three ETFs—QTUM, BOTZ, and ROBO—...
Strategy shifted roughly 411 BTC to Coinbase Prime, prompting a fresh look at its cash strategy. The move has revived...
In a rare private hour-long session, Senator Bernie Sanders pressed for public ownership of AI firms, while OpenAI ch...
When veterans return with their first original album in years, the headlines focus on the music. What truly stands ou...
BlackRock unveils the iShares Bitcoin Premium Income ETF, BITA, a yield-focused crypto product using an active covere...
Lawmakers are weighing the price of a $300 billion fund to rebuild Iran after conflict. The outcome could reshape deb...
Berkshire Hathaway's Greg Abel recently bought Macy's stock, sparking questions about value and strategy. This in-dep...
The iShares Semiconductor ETF has surged this year, but its strength now hinges on AI infrastructure spending guidanc...
Dive into a practical look at how Kleiner Perkins evaluates AI startups, drawn from the transcript: mamoon hamid, kle...
Stocks ended mixed as the Dow stayed relatively calm while Nasdaq slipped. Earnings, rates, and sector rotation shape...
A provocative message about mental health care can ripple through budgets, markets, and everyday money decisions. Thi...